Brainsway (BWAY) Receives a Buy from Northland Securities

Tip Ranks
2025.11.12 14:26
portai
I'm PortAI, I can summarize articles.

Northland Securities analyst Carl Byrnes has maintained a Buy rating on Brainsway (BWAY) with a price target of $23.00. Byrnes, who has an average return of -4.1% and a 36.78% success rate, focuses on the Healthcare sector. The current analyst consensus on Brainsway is a Strong Buy, with an average price target of $19.67.

Northland Securities analyst Carl Byrnes maintained a Buy rating on Brainsway today and set a price target of $23.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Byrnes is an analyst with an average return of -4.1% and a 36.78% success rate. Byrnes covers the Healthcare sector, focusing on stocks such as Brainsway, Alvotech, and BioLife Solutions.

Currently, the analyst consensus on Brainsway is a Strong Buy with an average price target of $19.67.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer